Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Research Platform On Urologic Cancer Treatment And Outcome (Registry Platform Urologic Cancer; CARAT)

NCT03374267 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT03374267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03374267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Research Platform On Urologic Cancer Treatment And Outcome (Registry Platform Urologic Cancer; CARAT)
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Recruiting
Start date
December 7, 2017
Completion date
March 31, 2034
Enrollment
2,230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma, urothelial carcinoma